Irene Carretero-Barrio
Overview
Explore the profile of Irene Carretero-Barrio including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
98
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cortes-Salgado A, Moreno-Moreno E, Carretero-Barrio I, Caniego-Casas T, Cristobal E, Del Campo-Albendea L, et al.
Gynecol Oncol
. 2025 Feb;
194:33-40.
PMID: 39947031
Background: HER2 antibody-drug conjugates like Trastuzumab deruxtecan (TDxd) have shown efficacy in HER2-low cancers, however the prevalence and clinical impact of HER2-low in endometrial cancer (EC) remains unclear. This study...
2.
Gonzalez-Martinez S, Palacios J, Carretero-Barrio I, Lanza V, Garcia-Cosio Piqueras M, Caniego-Casas T, et al.
Cells
. 2025 Feb;
14(3).
PMID: 39936988
The purpose of this study was to evaluate the suitability of formalin-fixed and paraffin-embedded (FFPE) samples and fixed fresh (FF) samples for single-cell RNA sequencing (scRNAseq). To this end, we...
3.
Fernandez-Abad M, Caniego-Casas T, Carretero-Barrio I, Calderay-Dominguez M, Saavedra C, Hardisson D, et al.
Am J Surg Pathol
. 2025 Jan;
49(3):294-302.
PMID: 39780328
Determining whether an ipsilateral breast carcinoma recurrence is a true recurrence or a new primary remains challenging based solely on clinicopathologic features. Algorithms based on these features have estimated that...
4.
Carretero-Barrio I, Pijuan L, Illarramendi A, Curto D, Lopez-Rios F, Estebanez-Gallo A, et al.
Sci Rep
. 2024 Oct;
14(1):24163.
PMID: 39406837
The incorporation of digital pathology in clinical practice will require the training of pathologists in digital skills. Our study aimed to assess the reliability among pathologists in determining tumor percentage...
5.
Moreno-Moreno E, Caniego-Casas T, Carretero-Barrio I, Cortes A, Muriel A, Dominguez-Rullan J, et al.
Am J Surg Pathol
. 2024 Sep;
PMID: 39269025
In this study, molecular alterations in endometrial carcinoma (EC) recurrences were analyzed. We aimed to identify genes implicated in tumor progression and to evaluate whether histologic and molecular type shifting...
6.
Ruz-Caracuel I, Caniego-Casas T, Alonso-Gordoa T, Carretero-Barrio I, Arino-Palao C, Santon A, et al.
Endocr Pathol
. 2024 Jul;
35(3):207-218.
PMID: 38958823
Medullary thyroid carcinoma (MTC) is a rare cancer derived from neuroendocrine C-cells of the thyroid. In contrast to other neuroendocrine tumors, a histological grading system was lacking until recently. A...
7.
Gonzalez-Martinez S, Kajabova V, Perez-Mies B, Carretero-Barrio I, Caniego-Casas T, Sarrio D, et al.
Virchows Arch
. 2024 May;
485(2):291-297.
PMID: 38713384
The proposed role of CDH1 (E-cadherin gene) methylation as a mechanism of gene inactivation in invasive lobular carcinoma (ILC) remains inconclusive. For many years, CDH1 promoter hypermethylation has been regarded...
8.
Pizarro D, Romero I, Perez-Mies B, Redondo A, Caniego-Casas T, Carretero-Barrio I, et al.
Int J Mol Sci
. 2023 Jul;
24(13).
PMID: 37446361
Early stages are under-represented in studies on the molecular and immune features of high-grade serous ovarian carcinoma (HGSOC), and specific studies focused on early-stage HGSOC are required for a better...
9.
Carretero-Barrio I, Caniego-Casas T, Rosas M, Sanchez M, Martinez-Janez N, Chiva M, et al.
Cancers (Basel)
. 2023 Mar;
15(6).
PMID: 36980575
Xpert Breast Cancer STRAT4 is a RT-qPCR platform that studies the mRNA expression of , , and , providing a positive or negative result for each of these breast cancer...
10.
Perez-Mies B, Caniego-Casas T, Bardi T, Carretero-Barrio I, Benito A, Garcia-Cosio M, et al.
Front Med (Lausanne)
. 2022 Nov;
9:976759.
PMID: 36405615
The development of lung fibrosis is a major concern in patients recovered from severe COVID-19 pneumonia. This study aimed to document the evolution of diffuse alveolar damage (DAD) to the...